Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Circulation
|
January 11, 2000
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications
R B Rothman, M H Baumann, J E Savage, et al.
Psychopharmacology Series
|
January 1, 1993
Developmental regulation of 5-HT2 and 5-HT1c receptor gene expression in rat brain
R D Ciaranello, J Aimi, R Dean, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Receptor changes in endotoxemia
J A Spitzer, E B Rodriguez de Turco, I V Deaciuc, et al.
Brain Research. Developmental Brain Research
|
February 1, 1989
Cross-linking of [125I]beta-endorphin to mu-opioid receptors during development
S McLean, R B Rothman, D M Chuang, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Modification of protein kinase C (PKC) activity and diacylglycerol (DAG) accumulation in hepatocytes in continuous endotoxemia
J A Spitzer, I V Deaciuc, E B Rodriguez de Turco, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors
M R Seggel, M Y Yousif, R A Lyon, et al.
Molecular Pharmacology
|
October 20, 2001
Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells
J A Gray, D J Sheffler, A Bhatnagar, et al.
Journal of Neurochemistry
|
December 1, 2004
Low nNOS protein in the locus coeruleus in major depression
B Karolewicz, K Szebeni, C A Stockmeier, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2000
A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism
K Kristiansen, W K Kroeze, D L Willins, et al.
Annals of the New York Academy of Sciences
|
February 3, 1999
Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo
D L Willins, L Alsayegh, S A Berry, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Circulation
|
January 11, 2000
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications
R B Rothman, M H Baumann, J E Savage, et al.
Psychopharmacology Series
|
January 1, 1993
Developmental regulation of 5-HT2 and 5-HT1c receptor gene expression in rat brain
R D Ciaranello, J Aimi, R Dean, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Receptor changes in endotoxemia
J A Spitzer, E B Rodriguez de Turco, I V Deaciuc, et al.
Brain Research. Developmental Brain Research
|
February 1, 1989
Cross-linking of [125I]beta-endorphin to mu-opioid receptors during development
S McLean, R B Rothman, D M Chuang, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Modification of protein kinase C (PKC) activity and diacylglycerol (DAG) accumulation in hepatocytes in continuous endotoxemia
J A Spitzer, I V Deaciuc, E B Rodriguez de Turco, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors
M R Seggel, M Y Yousif, R A Lyon, et al.
Molecular Pharmacology
|
October 20, 2001
Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells
J A Gray, D J Sheffler, A Bhatnagar, et al.
Journal of Neurochemistry
|
December 1, 2004
Low nNOS protein in the locus coeruleus in major depression
B Karolewicz, K Szebeni, C A Stockmeier, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2000
A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism
K Kristiansen, W K Kroeze, D L Willins, et al.
Annals of the New York Academy of Sciences
|
February 3, 1999
Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo
D L Willins, L Alsayegh, S A Berry, et al.
Page
of 12